Kolexia
Devauchelle Valerie
Rhumatologie
Hôpital Cavale Blanche
Brest, France
417 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome de Gougerot-Sjögren Arthrite Polyarthrite rhumatoïde Rhumatisme inflammatoire des ceintures Artérite à cellules géantes Maladies auto-immunes Arthrite juvénile Inflammation Artérite

Industries

Novartis
37 collaboration(s)
Dernière en 2023
Abbvie
32 collaboration(s)
Dernière en 2023
Galapagos SASU
22 collaboration(s)
Dernière en 2023
Pfizer
16 collaboration(s)
Dernière en 2023

Dernières activités

Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
The Lancet. Rheumatology   01 mars 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.
Rheumatology (Oxford, England)   01 mars 2024
Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training Initiative.
Rheumatology and therapy   19 février 2024
Reply.
Arthritis & rheumatology (Hoboken, N.J.)   07 février 2024
Estimated prevalence, incidence and healthcare costs of Sjögren's syndrome in France: a national claims-based study.
RMD open   02 février 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.
Seminars in arthritis and rheumatism   23 janvier 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial.
The Lancet. Rheumatology   22 janvier 2024
History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis.
RMD open   04 janvier 2024
Combined anti-Ro52/TRIM21 and anti-Ro60/SSA antibodies are associated with increased Sjögren's disease severity through interferon pathway activation.
Arthritis & rheumatology (Hoboken, N.J.)   21 décembre 2023
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Journal of autoimmunity   18 décembre 2023